Although there seems to be no consensus about the significance of immune infiltrates in brain tumors due to local immune suppression, there is increasing evidence that associates a beneficial outcome with increased CD3+/CD8+ infiltrates in glioblastoma patients (51, 52). The gene discussed is CD8A; the disease is brain neoplasm.